Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression

Modern Pathology

Volumn 25, Issue 9, 2012, Pages 1227-1235

  Hartmann, Elena M ^a   Be, Sílvia ^b   Navarro, Alba ^b   Trapp, Vanessa ^a   Campo, Elías ^b   Ott, German ^c   Rosenwald, Andreas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

7p genomic status; IGF2BP3; mantle cell lymphoma; proliferation

Indexed keywords

KI 67 ANTIGEN; SOMATOMEDIN A; SOMATOMEDIN B MRNA BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 84865786481     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.84     Document Type: Article

References (26)

1. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-762.
2. Royo C, Salaverria I, Hartmann EM, et al. The complex landscape of genetic alterations in mantle cell lymphoma. Semin Cancer Biol 2011;21:322-334.
3. Allen JE, Hough RE, Goepel JR, et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 2002;116:291-298.
4. Bea S, Ribas M, Hernandez JM, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999;93:4365-4374.
5. Hartmann EM, Campo E, Wright G, et al. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood 2010;116:953-961.
6. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3: 185-197.
7. Blenk S, Engelmann JC, Pinkert S, et al. Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. BMC Cancer 2008;8:106.
8. Nielsen J, Christiansen J, Lykke-Andersen J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-1270.
9. Yaniv K, Yisraeli JK. The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 2002;287:49-54.
10. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-928.
11. Mueller-Pillasch F, Lacher U, Wallrapp C, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997;14:2729-2733.
12. Findeis-Hosey JJ, Yang Q, Spaulding BO, et al. IGF2BP3 expression is correlated with histologic grade of lung adenocarcinoma. Hum Pathol 2010;41:477-484.
13. Li D, Yan D, Tang H, et al. IGF2BP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol 2009;16:3499-3506.
14. Hoffmann NE, Sheinin Y, Lohse CM, et al. External validation of IGF2BP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. J Urol 2008;179:133-134.
15. Schaeffer DF, Owen DR, Lim HJ, et al. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer 2010;10:59.
16. Jeng YM, Chang CC, Hu FC, et al. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008;48:1118-1127.
17. Chen ST, Jeng YM, Chang CC, et al. Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma. Cancer Sci 2011;102:2191-2198.
18. Kobel M, Xu H, Bourne PA, et al. IGF2BP3 (IGF2BP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol 2009;22:469-475.
19. King RL, Pasha T, Roullet MR, et al. IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue. Hum Pathol 2009;40:1699-1705.
20. Bea S, Salaverria I, Armengol L, et al. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 2009;113:3059-3069.
21. Swerdlow SHCE, Harris NL, Jaffe ES, et al. (ed). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008.
22. Katzenberger T, Petzoldt C, Holler S, et al. The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 2006;107: 3407.
23. Determann O, Hoster E, Ott G, et al. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 2008;111:2385-2387.
24. Ponzoni M, Doglioni C, Caligaris-Cappio F. Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment. Semin Diagn Pathol 2011;28: 161-166.
25. Maki RG. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 2010;28:4985-4995.
26. Vishwamitra D, Shi P, Wilson D, et al. Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma. Haematologica 2011;96:871-880.